Congress Must Act to Preserve Expert Advisory Panels After Recent HHS Firings
Recent dismissals of key health advisory officials highlight a growing challenge to scientifically based policymaking.
Trend: Federal health advisory bodies are facing unprecedented turnover that threatens their statutory mandate for expertise and independence.
In September, Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the two vice chairs of the U.S. Preventive Services Task Force. The task force serves as a critical advisory entity to HHS, reviewing scientific evidence to recommend whether private insurers must cover services such as cancer screenings at no cost to patients.
Congress established the task force as part of the Affordable Care Act and explicitly required that it be staffed by individuals with “appropriate expertise” and, “to the extent practicable, not subject to political pressure.” The recent firings directly intersect with those statutory provisions.
The September action follows a broader pattern of advisory committee disruptions. In 2025, the Trump administration terminated 151 advisory committees at scientific government agencies, including 75 within HHS. Those remaining were reportedly altered or ignored.
Also in 2025, Kennedy terminated the entire Advisory Committee on Immunization Practices, which issues public recommendations on vaccines. His appointed replacements are described as sympathetic to his unscientific views, and a majority lack substantial expertise in vaccines and immunology.
These developments raise questions about how Congress can respond to protect the integrity of advisory panels that the law specifically mandates to be expert‑driven and insulated from political influence.
Ensuring that advisory committees retain their expertise and independence may become a defining legislative challenge in the coming months.
